Sanjay Divakaran

Sanjay Divakaran

Auto-generated profile, based on publicly available information

Sanjay Divakaran

Brigham and Women’s Hospital

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 June 2018 in JACC
Verified
Journal Article
Closed access
EDErsilia M. DeFilippis
Ersilia M. DeFilippis
ASAvinainder Singh
Avinainder Singh
SDSanjay Divakaran
Sanjay Divakaran
AGAnkur Gupta
Ankur Gupta
BCBradley L. Collins
Bradley L. Collins
RBRon Blankstein
Ron Blankstein

26 February 2024 in JACC
Verified
Journal Article
Closed access
ABAdam N. Berman
Adam N. Berman
DBDavid W. Biery
David W. Biery
SBStephanie A. Besser
Stephanie A. Besser
ASAvinainder Singh
Avinainder Singh
Arthur ShiyovichArthur Shiyovich
Arthur Shiyovich
RBRon Blankstein
Ron Blankstein

27 September 2023 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
ASAna Carolina Do A.H. Souza
Ana Carolina Do A.H. Souza
MRMichael H. Rosenthal
Michael H. Rosenthal
FMFilipe A. Moura
Filipe A. Moura
SDSanjay Divakaran
Sanjay Divakaran
MOMichael T. Osborne
Michael T. Osborne
VTViviany R. Taqueti
Viviany R. Taqueti

20 January 2025 in European Heart Journal
Verified
Journal Article
Closed access
ASAna Carolina Do A H Souza
Ana Carolina Do A H Souza
ATAmelie S Troschel
Amelie S Troschel
JMJan P Marquardt
Jan P Marquardt
IHIbrahim Hadžić
Ibrahim Hadžić
BFBorek Foldyna
Borek Foldyna
VTViviany R Taqueti
Viviany R Taqueti
Background and Aims: Skeletal muscle (SM) fat infiltration, or intermuscular adipose tissue (IMAT), reflects muscle quality and is associated with inflammation, a key determinant in cardiometabolic disease. Coronary flow reserve (CFR), a marker of coronary microvascular dysfunction (CMD), is independently associated with body mass index (BMI), inflammation and risk of heart failure, myocardial infarction, and death. The relationship between SM quality, CMD, and cardiovascular outcomes is not known. Methods: Consecutive patients (n = 669) undergoing evaluation for coronary artery disease with cardiac stress positron emission tomography demonstrating normal perfusion and preserved left ventricular ejection fraction were followed over a median of 6 years for major adverse cardiovascular events (MACEs), including death and hospitalization for myocardial infarction or heart failure. Coronary flow reserve was calculated as stress/rest myocardial blood flow. Subcutaneous adipose tissue (SAT), SM, and IMAT areas (cm2) were obtained from simultaneous positron emission tomography attenuation correction computed tomography using semi-automated segmentation at the 12th thoracic vertebra level. Results: Median age was 63 years, 70% were female, and 46% were nonwhite. Nearly half of patients were obese (46%, BMI 30–61 kg/m2), and BMI correlated highly with SAT and IMAT (r = .84 and r = .71, respectively, P < .001) and moderately with SM (r = .52, P < .001). Decreased SM and increased IMAT, but not BMI or SAT, remained independently associated with decreased CFR (adjusted P = .03 and P = .04, respectively). In adjusted analyses, both lower CFR and higher IMAT were associated with increased MACE [hazard ratio 1.78 (95% confidence interval 1.23–2.58) per −1 U CFR and 1.53 (1.30–1.80) per +10 cm2 IMAT, adjusted P = .002 and P < .0001, respectively], while higher SM and SAT were protective [hazard ratio .89 (.81–.97) per +10 cm2 SM and .94 (.91–.98) per +10 cm2 SAT, adjusted P = .01 and .003, respectively]. Every 1% increase in fatty muscle fraction [IMAT/(SM + IMAT)] conferred an independent 2% increased odds of CMD [CFR <2, odds ratio 1.02 (1.01–1.04), adjusted P = .04] and a 7% increased risk of MACE [hazard ratio 1.07 (1.04–1.09), adjusted P < .001]. There was a significant interaction between CFR and IMAT, not BMI, such that patients with both CMD and fatty muscle demonstrated highest MACE risk (adjusted P = .02). Conclusions: Increased intermuscular fat is associated with CMD and adverse cardiovascular outcomes independently of BMI and conventional risk factors. The presence of CMD and SM fat infiltration identified a novel at-risk cardiometabolic phenotype.

1 July 2020 in European Heart Journal
Verified
Journal Article
Open access
PDF file
WZWunan Zhou
Wunan Zhou
JBJenifer M Brown
Jenifer M Brown
NBNavkaranbir S Bajaj
Navkaranbir S Bajaj
ACAlvin Chandra
Alvin Chandra
SDSanjay Divakaran
Sanjay Divakaran
MCMarcelo F Di Carli
Marcelo F Di Carli
Hypertension is a well-established heart failure (HF) risk factor, especially in the context of adverse left ventricular (LV) remodelling. We aimed to use myocardial flow reserve (MFR) and global longitudinal strain (GLS), markers of subclinical microvascular and myocardial dysfunction, to refine hypertensive HF risk assessment. Consecutive patients undergoing symptom-prompted stress cardiac positron emission tomography (PET)-computed tomography and transthoracic echocardiogram within 90 days without reduced left ventricular ejection fraction (<40%) or flow-limiting coronary artery disease (summed stress score ≥ 3) were included. Global MFR was quantified by PET, and echocardiograms were retrospectively analysed for cardiac structure and function. Patients were followed over a median 8.75 (Q1–3 4.56–10.04) years for HF hospitalization and a composite of death, HF hospitalization, MI, or stroke. Of 194 patients, 155 had adaptive LV remodelling while 39 had maladaptive remodelling, which was associated with lower MFR and impaired GLS. Across the remodelling spectrum, diastolic parameters, GLS, and N-terminal pro-B-type natriuretic peptide were independently associated with MFR. Maladaptive LV remodelling was associated with increased adjusted incidence of HF hospitalization and death. Importantly, the combination of abnormal MFR and GLS was associated with a higher rate of HF hospitalization compared to normal MFR and GLS [adjusted hazard ratio (HR) 3.21, 95% confidence interval (CI) 1.09–9.45, P = 0.034), including in the adaptive remodelling subset (adjusted HR 3.93, 95% CI 1.14–13.56, P = 0.030). We have demonstrated important associations between coronary microvascular dysfunction and myocardial mechanics that refine disease characterization and HF risk assessment of patients with hypertension based on subclinical target organ injury.